Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Approved for use in oncology care according to FDA-approved indications.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.
Relapsed/refractory B-cell Acute Lymphoblastic Leukemia (ALL) or CD33-positive Acute Myeloid Leukemia (AML).
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Myelofibrosis, Polycythemia Vera, and acute/chronic Graft-versus-Host Disease (GVHD).